US Compounding Pharmacies Market Forecast to 2027 - COVID-19 Impact and Country Analysis by Product (Oral Medications, Topical Medications, Suppositories, and Others) and Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, and Others)

Publication Month: Mar 2021 | Report Code: TIPRE00019845 | No. of Pages: 111 | Category: Pharmaceuticals | Status: Published
Covid

The US compounding pharmacies market is expected to reach US$ 5,069.56 million by 2027 from US$ 3,079.64 million in 2019. The market is anticipated to grow at a CAGR of 6.5% from 2020 to 2027.

 

The growth of the market in the country is driven by the factors such as the drug shortage crisis in the US and benefits associated with compounded medications. However, product recalls and stringent regulatory requirements across the country are likely to hinder the compounding pharmacies market growth during the forecast period.

 

The US is encountering a rapid increase in drug shortage, which has caused various difficulties for health care facilities, clinicians, patients, and federal regulators. Many factors are involved in drug shortage, including challenges in manufacturing, acquisition of raw materials, regulatory issues, and business arrangements, as well as several other disruptions within the supply chain. According to the American Society of Health-System Pharmacists, drug shortages can negatively affect drug therapy and delay medical procedures resulting in medication errors. Drug shortages range from simple medicines, such as buffered aspirin, to life-saving medications—such as cancer antibiotics and cancer chemotherapy agents—and emergency medications, such as epinephrine. Healthcare professionals, especially pharmacists, along with the US government and drug manufacturers, are consistently working on managing this public-health crisis. Health care personnel have started to formulate solutions to a drug shortage. Compounding pharmacies are considered a viable source of drugs that are in short supply.

A compounding pharmacy or specialty pharmacy makes drugs recommended by doctors for patients that are not commercially available. The demand for compounding pharmacy is growing due to many benefits associated with it. For instance, compounding pharmacy is highly recommended to patients with allergies or to those who are very young and need a small dosage of a particular medication. Additionally, pharmacists can alter ingredients if patients are lactose intolerant, glucose intolerant, or allergic to the commercial drug's unnecessary dye. Moreover, pharmacists can lessen the dosage for children or can add flavor for children and double the dose for older adults depending on their needs. For patients who are delicate to oral administration, one can change pill formulation into a liquid for the ease of taking it. Compounding pharmacists can get access to medications that have been discontinued to patients who still depend on them. They can recreate the pharmaceutical-based ingredients to retain patients’ health. 

Thus, drug shortage crisis in US and benefits associated with compounded medications are likely to propel the growth of the compounding pharmacy market in the U.S. during the forecast period.

 

US Compounding Pharmacies Market Revenue and Forecast to 2027 (US$ Million)

US Compounding Pharmacies Market Revenue and Forecast to 2027 (US$ Million)

Get more information on this report :


 

US Compounding Pharmacies – Market Segmentation

 

By Product

  • Oral Medications
  • Topical Medications
  • Suppositories
  • Others

By Therapeutic Area

  • Pain Medications
  • Dermatological Applications
  • Hormone Replacement Therapies
  • Others

Company Profiles

  • Fagron
  • Triangle Compounding Pharmacy
  • Institutional Pharmacy Solutions, LLC
  • B. Braun Melsungen AG
  • Pharmedium Services LLC
  • Fresenius Kabi AG
  • Avella Specialty Pharmacy
  • Pencol Compounding Pharmacy
  • Vertisis Custom Pharmacy
  • US Compounding Inc.

 

1. Introduction

1.1          Study Scope

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          US Compounding Pharmacies Market – By Product

1.3.2          US Compounding Pharmacies Market – By Therapeutic Area

2. Key Takeaways

3. Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4. US Compounding Pharmacies Market Landscape

4.1          Market Overview

4.2          PEST Analysis

4.2.1          US: PEST Analysis

4.3          Expert Opinion

5. US Compounding Pharmacies Market – Key Market Dynamics

5.1          Market Drivers

5.1.1          Drug Shortage Crisis in US

5.1.2          Benefits Associated with Compounded Medications

5.2          Market Restraints

5.2.1          Product Recalls and Stringent Regulatory Requirements

5.3          Market Opportunities

5.3.1          Growing Demand for Compounding Pharmacy During COVID-19

5.4          Future Trends

5.4.1          Growing Outsourcing Facilities for Manufacturing and Sales of Products

5.5          Impact Analysis

6. Compounding Pharmacies– US Market Analysis

6.1          US Compounding Pharmacies Market Overview

6.2          Market Positioning of Key Players

7. US Compounding Pharmacies Market Analysis– Product

7.1          Overview

7.2          US Compounding Pharmacies Market, by Product 2019 & 2027 (%)

7.3          Oral Medications

7.3.1          Overview

7.3.2          US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)

7.4          Topical Medications

7.4.1          Overview

7.4.2          US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)

7.5          Suppositories

7.5.1          Overview

7.5.2          US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)

7.6          Others

7.6.1          Overview

7.6.2          Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. US Compounding Pharmacies Market Analysis – Therapeutic Area

8.1          Overview

8.2          US Compounding Pharmacies Market, By Therapeutic Area 2019 & 2027 (%)

8.3          Pain Medications

8.3.1          Overview

8.3.2          US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)

8.4          Hormone Replacement Therapies

8.4.1          Overview

8.4.2          US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)

8.5          Dermatological Applications

8.5.1          Overview

8.5.2          US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)

8.6          Others

8.6.1          Overview

8.6.2          US Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Impact of COVID-19 Pandemic on US Compounding Pharmacies Market

9.1          US: Impact Assessment of COVID-19 Pandemic

10. Industry Landscape

10.1        Overview

10.2        Growth Strategies Done by the Companies in the Market, (%)

10.3        Organic Developments

10.3.1        Overview

10.4        Inorganic Developments

10.4.1        Overview

11. Company Profiles

11.1        Fagron, Inc.

11.1.1        Key Facts

11.1.2        Business Description

11.1.3        Products and Services

11.1.4        Financial Overview

11.1.5        SWOT Analysis

11.1.6        Key Developments

11.2        Triangle Compounding Pharmacy

11.2.1        Key Facts

11.2.2        Business Description

11.2.3        Products and Services

11.2.4        Financial Overview

11.2.5        SWOT Analysis

11.2.6        Key Developments

11.3        Institutional Pharmacy Solutions, LLC

11.3.1        Key Facts

11.3.2        Business Description

11.3.3        Products and Services

11.3.4        Financial Overview

11.3.5        SWOT Analysis

11.3.6        Key Developments

11.4        B.Braun Melsungen AG

11.4.1        Key Facts

11.4.2        Business Description

11.4.3        Products and Services

11.4.4        Financial Overview

11.4.5        SWOT Analysis

11.4.6        Key Developments

11.5        PharMEDium Healthcare Holdings, Inc.

11.5.1        Key Facts

11.5.2        Business Description

11.5.3        Products and Services

11.5.4        Financial Overview

11.5.5        SWOT Analysis

11.5.6        Key Developments

11.6        Fresenius Kabi AG

11.6.1        Key Facts

11.6.2        Business Description

11.6.3        Products and Services

11.6.4        Financial Overview

11.6.5        SWOT Analysis

11.6.6        Key Developments

11.7        Avella specialty pharmacy

11.7.1        Key Facts

11.7.2        Business Description

11.7.3        Products and Services

11.7.4        Financial Overview

11.7.5        SWOT Analysis

11.7.6        Key Developments

11.8        Pencol Compounding Pharmacy

11.8.1        Key Facts

11.8.2        Business Description

11.8.3        Products and Services

11.8.4        Financial Overview

11.8.5        SWOT Analysis

11.8.6        Key Developments

11.9        Vertisis Custom Pharmacy

11.9.1        Key Facts

11.9.2        Business Description

11.9.3        Products and Services

11.9.4        Financial Overview

11.9.5        SWOT Analysis

11.9.6        Key Developments

1.44        US Compounding Inc.

1.44.1        Key Facts

1.44.2        Business Description

1.44.3        Products and Services

1.44.4        Financial Overview

1.44.5        SWOT Analysis

1.44.6        Key Developments

12. Appendix

12.1        About The Insight Partners

12.2        Glossary of Terms


LIST OF TABLES

Table 1.              A few drugs that are in short supply are listed below:

Table 2.              Organic Developments Done By Companies

Table 3.              Inorganic Developments Done By Companies

Table 4.              Glossary of Terms, US Compound Pharmacies Market

 


LIST OF FIGURES

Figure 1.            US Compounding Pharmacies Market Segmentation

Figure 2.            US Compounding Pharmacies Market Overview

Figure 3.            Topical Medication is Expected to Show Remarkable Growth During Forecast Period

Figure 4.            US Compounding Pharmacies Market, Industry Landscape

Figure 5.            US: PEST Analysis

Figure 6.            Expert Opinion

Figure 7.            US Compounding Pharmacies Market Impact Analysis of Drivers and Restraints

Figure 8.            Overview of US Compounding Pharmacies Market

Figure 9.            Market Positioning Of Key Players In US Compounding Pharmacies Market

Figure 10.          US Compounding Pharmacies Market, By Product 2019 & 2027 (%)

Figure 11.          US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.          US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.          US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.          US Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.          US Compounding Pharmacies Market, by Therapeutic Area 2019 & 2027 (%)

Figure 16.          US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.          US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.          US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.          US Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.          Impact of COVID-19 Pandemic on Compounding Pharmacies Market in the US

Figure 21.          Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - US Compounding Pharmacies Market

  1. Fagron
  2. Triangle compounding pharmacy
  3. Institutional pharmacy solutions, llc
  4. B. Braun melsungen ag
  5. Pharmedium services llc
  6. Fresenius kabi ag
  7. Avella specialty pharmacy
  8. Pencol Compounding Pharmacy
  9. Vertisis custom pharmacy
  10. US Compounding Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US compounding pharmacy market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the US compounding pharmacy market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00019845
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing